0      0

AONN+ Annual 2020

SAT01 - Industry Sponsored Session | Identifying Appropriate Patients for NINLARO® (ixazomib): An Oral Treatment for Patients with Multiple Myeloma (non-CE) Presentation by Takeda

Nov 7, 2020 7:30am ‐ Nov 7, 2020 8:45am


This NINLARO education program is intended to provide you with:

  • An overview of multiple myeloma
  • Highlight evolving treatment strategies
  • Present NINLARO clinical trial data
    • Efficacy
    • Safety
    • Dosing and administration
  • Discuss the expanding role of nurses in the care of multiple myeloma patients
  • Discuss appropriate patients for treatment with the NINLARO regimen


You must be logged in and own this session in order to post comments.